U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. OCTAGAM
  1. Approved Blood Products

STN: 125062
Proper Name: Immune Globulin Intravenous (Human)
Tradename: OCTAGAM
Manufacturer: OCTAPHARMA Pharmazeutika Produktionsges.m.b.H.
Indication:

Indicated for the treatment of:

  • Octagam is an immune globulin intravenous (human), 5% liquid, indicated for treatment of primary humoral immunodeficiency (PI).
  • Octagam 10% is an immune globulin intravenous (human) liquid preparation indicated for the treatment of:
    • Chronic immune thrombocytopenic purpura (ITP) in adults
    • Dermatomyositis (DM) in adults

Product Information

Supporting Documents

Back to Top